Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Ghobrial

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Minerva Chirurgica|November 7, 2003
Treatment for recurrent hepatitis CR M Ghobrial
Clinics in Liver Disease|March 10, 2001
Surgical advances in liver transplantation. Living related and split donorsR M Ghobrial, F Amersi, R W Busuttil
American Journal of Surgery|January 4, 2001
Advances in pediatric liver and intestinal transplantationR M Ghobrial, D G Farmer, F Amersi, et al.
Critical Reviews in Immunology|June 3, 1999
Th1 and Th2 cytokines in organ transplantation: paradigm lost?Y Zhai, R M Ghobrial, R W Busuttil, et al.
Clinical Transplants|September 6, 2002
Liver transplantation at Dumont-UCLA Transplant Center: an experience with over 3,000 casesD M Anselmo, A Baquerizo, S Geevarghese, et al.
Transplantation Proceedings|September 10, 2003
Biliary complications after adult living donor liver transplantationC Fondevila, R M Ghobrial, J Fuster, et al.
Pharmacotherapy|December 17, 1997
Mycophenolate mofetilT M Sievers, S J Rossi, R M Ghobrial, et al.
Transplantation Proceedings|December 20, 2007
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis BM A Zimmerman, R M Ghobrial, M J Tong, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Mycophenolate mofetil: effects on clinical transplantationC D Holt, T M Sievers, R M Ghobrial, et al.
Transplantation Proceedings|May 28, 2005
Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejectionN V Semiletova, X-D Shen, D M Feldman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Minerva Chirurgica|November 7, 2003
Treatment for recurrent hepatitis CR M Ghobrial
Clinics in Liver Disease|March 10, 2001
Surgical advances in liver transplantation. Living related and split donorsR M Ghobrial, F Amersi, R W Busuttil
American Journal of Surgery|January 4, 2001
Advances in pediatric liver and intestinal transplantationR M Ghobrial, D G Farmer, F Amersi, et al.
Critical Reviews in Immunology|June 3, 1999
Th1 and Th2 cytokines in organ transplantation: paradigm lost?Y Zhai, R M Ghobrial, R W Busuttil, et al.
Clinical Transplants|September 6, 2002
Liver transplantation at Dumont-UCLA Transplant Center: an experience with over 3,000 casesD M Anselmo, A Baquerizo, S Geevarghese, et al.
Transplantation Proceedings|September 10, 2003
Biliary complications after adult living donor liver transplantationC Fondevila, R M Ghobrial, J Fuster, et al.
Pharmacotherapy|December 17, 1997
Mycophenolate mofetilT M Sievers, S J Rossi, R M Ghobrial, et al.
Transplantation Proceedings|December 20, 2007
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis BM A Zimmerman, R M Ghobrial, M J Tong, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Mycophenolate mofetil: effects on clinical transplantationC D Holt, T M Sievers, R M Ghobrial, et al.
Transplantation Proceedings|May 28, 2005
Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejectionN V Semiletova, X-D Shen, D M Feldman, et al.
Pageof 5